key: cord-0839140-xbvmxawn
authors: Etoom, Mohammad; Alwardat, Sofian; Alwardat, Mohammad
title: Issues for conducting meta-analyses in COVID-19. Commentary on “Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis’’
date: 2020-04-28
journal: J Clin Virol
DOI: 10.1016/j.jcv.2020.104389
sha: 0b55ad38e919a35f080c1dd188aabdfd8fabfe56
doc_id: 839140
cord_uid: xbvmxawn

nan

In this context, we read with great interest the recent meta-analysis by Young Hu [2] 2-Heterogeneity. The heterogeneity in meta-analysis of COVID-19 is highly expected. In fact, Hu et al analysis shows large heterogeneity in their analyses measured by I 2 index. Identifying and quantifying the heterogeneity, using the appropriate analysis based on the heterogeneity as fixed or random models of analysis, prediction intervals, subgroups analyses, and meta-regression are required [3] to better and precise estimation for the effect size in the meta-analysis that will be one of the primary factors for COVID-19 evidence-based practice.

3-Availability of meta-analysis data. Because of the growing number in COVID-19 researches, meta-analysis, and updated meta-analysis will be increased. The availability of meta-analysis statistical data and assessment of quality or risk of bias in included articles will make conducting of new meta-analysis or updated meta-analysis easier and faster with all respect for institutions' policies, and copyrights. 

All authors declare no conflicts of interest. References: 1-World health organization

Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis

Introduction to meta-analysis